BB
Benjamin Burnett Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
35
Avg Return
Past Year
Past Year
10%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
83.3%
Neutral
16.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $30 |
50%
upside
| 1 | -25% |
0
%
| 27 Feb ‘26 5 days ago |
|
|
|
Overweight
Maintained
| $49 |
14%
upside
| 2 | +2.4% |
0
%
| 27 Feb ‘26 5 days ago |
|
|
|
Overweight
Maintained
| $7 |
137%
upside
| 1 | -25% |
0
%
| 27 Feb ‘26 5 days ago |
|
|
|
Equal-Weight
Maintained
| $466 |
5%
downside
| 1 | – |
–
| 26 Feb ‘26 6 days ago |
|
|
|
Overweight
Maintained
| $43 |
47%
upside
| 1 | -0.02% |
0
%
| 26 Feb ‘26 6 days ago |
|
|
|
Overweight
Maintained
| $202 |
23%
upside
| 2 | +8.2% |
0
%
| 24 Feb ‘26 8 days ago |
|
|
|
Equal-Weight
Maintained
| $305 |
6%
downside
| 2 | – |
–
| 20 Feb ‘26 12 days ago |
|
|
|
Overweight
Maintained
| $86 |
34%
upside
| 1 | -2.4% |
0
%
| 20 Feb ‘26 12 days ago |
|
|
|
Overweight
Maintained
| $208 |
39%
upside
| 2 | -13% |
0
%
| 20 Feb ‘26 12 days ago |
|
|
|
Overweight
Maintained
| $27 |
97%
upside
| 2 | +46% |
0
%
| 12 Feb ‘26 20 days ago |
|
|
|
Overweight
Initiated
| $43 |
47%
upside
| 1 | +10% |
0
%
| 2 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $45 |
106%
upside
| 1 | +11% |
0
%
| 30 Dec ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $9 |
60%
upside
| 1 | -8% |
0
%
| 18 Dec ‘25 2 months ago |
|